Dr. David Edward Marinier, MD

Dr. Marinier practices at Gundersen Lutheran Medical Center - Dialysis in La Crosse, Wisconsin.

Dr. Marinier's NPI, 1851412555, was assigned on April 2, 2007. Dr. Marinier holds Wisconsin license 61114.

Dr. Marinier's primary practice is Gundersen Lutheran Medical Center - Dialysis, at 1910 South Ave, Heritage Building 2 West, La Crosse, WI 54601 in La Crosse County. The practice phone is (608) 775-3176.

Dr. Marinier's primary practice is Gundersen Lutheran Medical Center - Dialysis in La Crosse, Wisconsin. Dr. Marinier is also affiliated with Gundersen Lutheran Medical Center. The medical group on file is Gundersen Lutheran Medical Center. Dmand AI also links Dr. Marinier to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account. Dr. Marinier's employer is on file too: a dialysis center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marinier practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Marinier's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Marinier's licenses on file in 2 states: Wisconsin and Illinois.

CMS data shows 554 Medicare services from Dr. Marinier across 4 procedure codes in 2024, for 169 Medicare patients. Medicare paid $30,084 for them.

CMS counts 169 Medicare patients who saw Dr. Marinier in 2024. The largest group is 65 to 74, with 69 patients. 72% of them have cancer, and 72% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marinier's median patient age at 71, with 55% women.

In 2024, Dr. Marinier wrote 882 Medicare Part D claims for 105 patients. 71% of them were for generic drugs. CMS names the drug for 730 of them, across 22 drugs with 11 or more claims each, at $3,098,898 in total drug cost. In 2023, CMS named 658 claims across 18 drugs.

Dr. Marinier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marinier as offering telehealth.

Dmand AI links 7 papers to Dr. Marinier, published from 2016 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Dr. Marinier's most frequent co-authors are Dipesh Uprety, MD, Amir Bista and Peter J. Polewski, MD.

Dmand AI links Dr. Marinier to 10 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Gallbladder Neoplasms and Hodgkin Disease. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 5 general payments to Dr. Marinier from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Tempus AI, Inc paid the most, $88.